These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs. Hirashima M; Tashiro K; Hayashi H Immunology; 1984 Mar; 51(3):441-50. PubMed ID: 6365742 [TBL] [Abstract][Full Text] [Related]
6. Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration. Gosset P; Prin L; Capron M; Auriault C; Tonnel AB; Capron A Clin Exp Immunol; 1986 Sep; 65(3):654-63. PubMed ID: 3780047 [TBL] [Abstract][Full Text] [Related]
7. Eosinophil cell: pray tell us what you do! Afshar K; Vucinic V; Sharma OP Curr Opin Pulm Med; 2007 Sep; 13(5):414-21. PubMed ID: 17940487 [TBL] [Abstract][Full Text] [Related]
8. Priming of eosinophil recruitment in vivo by LPS pretreatment. Macari DM; Teixeira MM; Hellewell PG J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756 [TBL] [Abstract][Full Text] [Related]
9. Isolation of an eosinophil chemotactic lymphokine as a natural mediator for eosinophil chemotaxis from concanavalin A-induced skin reaction sites in guinea-pigs. Hirashima M; Tashiro K; Sakata K; Hirashima M Clin Exp Immunol; 1984 Jul; 57(1):211-9. PubMed ID: 6378462 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4. Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179 [TBL] [Abstract][Full Text] [Related]
11. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. Schröder JM; Noso N; Sticherling M; Christophers E J Leukoc Biol; 1996 Jan; 59(1):1-5. PubMed ID: 8558057 [TBL] [Abstract][Full Text] [Related]
14. Chemical mediators and adhesion molecules involved in eosinophil accumulation in vivo. Weg VB; Williams TJ Ann N Y Acad Sci; 1994 May; 725():146-55. PubMed ID: 8030986 [No Abstract] [Full Text] [Related]
15. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. Yawalkar N; Shrikhande M; Hari Y; Nievergelt H; Braathen LR; Pichler WJ J Allergy Clin Immunol; 2000 Dec; 106(6):1171-6. PubMed ID: 11112902 [TBL] [Abstract][Full Text] [Related]
16. [The role of eosinophilic leukocytes in inflammatory dermatoses]. Czarnetzki BM Hautarzt; 1980 Jun; 31(6):291-6. PubMed ID: 6997234 [TBL] [Abstract][Full Text] [Related]
17. [The role of eosinophils in inflammatory reactions]. Czarnetzki BM; Pawelzik B Fortschr Med; 1983 Dec; 101(47-48):2167-74. PubMed ID: 6323290 [TBL] [Abstract][Full Text] [Related]
18. The mediation of tissue eosinophilia in hypersensitivity reactions. V. Comparative study of tissue eosinophilia in the skin lesions of local and systemic passive cutaneous anaphylactic reactions. Hirashima M; Tashiro K; Hirotsu Y; Hayashi H Immunology; 1983 Sep; 50(1):85-91. PubMed ID: 6885112 [TBL] [Abstract][Full Text] [Related]
20. Isolation and partial characterization of an eosinophil chemotactic factor from metacestodes of Taenia taeniaeformis (ECF-Tt). Potter KA; Leid RW J Immunol; 1986 Mar; 136(5):1712-7. PubMed ID: 3512706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]